Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Captopril vs Carvedilol for Cardiotoxicity in Childhood Acute Leukemia
NCT06853951Phase 3Recruiting
- Sponsor
- Ain Shams University
- Start
- Jul 2023
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of captopril and carvedilol in Cardiotoxicity (2 arms), sponsored by Ain Shams University. Primary endpoint: Left Ventricular Ejection Fraction at 42 days. Started Jul 2023; status: recruiting.
02
Drugs
captoprilcarvedilol
03
Conditions
Cardiotoxicity
Beyond the preview
Go deeper on NCT06853951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06853951.